Ananiti-malaria drug touted by President Trump as a"game changer" for COVID-19 showed no benefit, according to an analysis of patients hospitalized in Veterans Health Administration medical centers.
The analysis found the two primary outcomes for people treated with hydroxychloroquine were death and the need for mechanical ventilation.
The analysis was conducted retrospectively, based on data from patients hospitalized with confirmed COVID-19 infections in all VA medical centers until April 11, 2020.
TVNL Comment: Read the second paragraph carefully. Self-anointed Dr. Trump is a charleton.
Over the span of four years, 50-year-old Fidda Mohammad Naasan and her family have been violently...
A Maryland truck driver suffered an “eye stroke” that left him blind, first in one eye...
When we talk about our inability to pay attention, to concentrate, we often mean and blame...
